Leyanira Torrealba - Publications

Biological therapies for inflammatory pouch disorders: insights and outcomes from the RESERVO study of GETECCU.

Journal: Therapeutic advances in gastroenterology

Published: October 14, 2025

Withdrawal of antitumour necrosis factor in inflammatory bowel disease patients in remission: a randomised placebo-controlled clinical trial of GETECCU.

Journal: Gut

Published: August 02, 2024

Types, behaviour and therapeutic requirements of inflammatory pouch disorders: Results from the RESERVO study of GETECCU.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: June 07, 2024

Trends in Targeted Therapy Usage in Inflammatory Bowel Disease: TRENDY Study of ENEIDA.

Journal: Pharmaceutics

Published: March 25, 2024

Effectiveness and safety of azathioprine for inflammatory pouch disorders: results from the RESERVO study of GETECCU.

Journal: Therapeutic advances in gastroenterology

Published: November 16, 2023

Impact of bread diet on intestinal dysbiosis and irritable bowel syndrome symptoms in quiescent ulcerative colitis: A pilot study.

Journal: PloS one

Published: August 04, 2023

Real-World Evidence of Tofacinitib in Ulcerative Colitis: Short-Term and Long-Term Effectiveness and Safety.

Journal: The American journal of gastroenterology

Published: July 13, 2022

Long-Term Outcomes of Biological Therapy in Crohn's Disease Complicated With Internal Fistulizing Disease: BIOSCOPE Study From GETECCU.

Journal: The American journal of gastroenterology

Published: July 11, 2022

RAID Prediction: Pilot Study of Fecal Microbial Signature With Capacity to Predict Response to Anti-TNF Treatment.

Journal: Inflammatory bowel diseases

Published: September 28, 2021

Endoscopic full-thickness resection in the rectum closed with PolyLoop-and-clips method using single-channel endoscope.

Journal: Endoscopy

Published: February 19, 2021

A Novel Grape-Derived Prebiotic Selectively Enhances Abundance and Metabolic Activity of Butyrate-Producing Bacteria in Faecal Samples.

Journal: Frontiers in microbiology

Published: December 10, 2020

Phase IV noninferiority controlled randomized trial to evaluate the impact on diagnostic thinking and patient management and the test-retest reproducibility of the Gaxilose test for hypolactasia diagnosis.

Journal: Medicine

Published: November 16, 2018